The government is close to announcing its plans to end the bailout of American International Group (AIG), returning the company to independence and recovering taxpayer funds.
The Treasury is planning to begin converting its $49 billion preferred stak…
Don’t kid yourself. Real privacy no longer exists in this country. From your hobbies to your income to your phone calls, pretty much everything about you is tracked by someone, somewhere. We’ve examined the most intrusive firms…
Novartis (NVS) agreed to sell the U.S. rights to bladder medicine Enablex for $400 million.
Ireland-based Warner Chilcott will take over the marketing, sales and manufacturing of the drug in the United States, Novartis said in a statement. The deal is expected to close by the end of October.
Novartis may also receive “milestone payments” of as much as $20 million.
In 2005, Novartis…
Continue reading Novartis Sells U.S. Rights to Enablex for $400 Million
Novartis Sells U.S. Rights to Enablex for $400 Million originally appeared on DailyFinance on Fri, 24 Sep 2010 06:46:00.
Filed Under: Company News, Health Care, Novartis, Insurance, Retail
Republicans in the House of Representatives promised to end “job-killing tax hikes” and repeal the health reform law as part of their campaign manifesto for the November election.
In their “Pledge to America,” House Republicans also say they will ban…
Changes to the U.S. health care system take effect today. But while the measures will clearly benefit many Americans, the new law’s real price tag is still a subject of fierce disagreement.
Continue reading Hea…